• Musculoskeletal pain support: Addressing persistent joint, back, or widespread pain beyond expected recovery timelines.
• Fibromyalgia management: Targeting diffuse pain, tenderness, or fatigue impacting daily function.
• Pain sensitivity optimisation: Enhancing thresholds and responses to physical or emotional stressors.
• Injury recovery enhancement: Reducing prolonged soreness, inflammation, or activity delays.
• Pain-mood integration: Linking anxiety, low mood, or sleep issues with pain patterns.
• Post-surgical/nerve pain evaluation: Exploring transitions from acute to chronic pain factors.
• Holistic pain strategies: Tailored lifestyle and nutritional support alongside standard care.

DNA Pain evaluates genetic variation across interconnected biological systems involved in the perception, regulation and persistence of pain. These include inflammatory signalling pathways, oxidative stress balance, methylation processes and cellular communication mechanisms that influence tissue sensitivity and recovery. This test is a valuable tool for any person experiencing chronic pain, post surgical nerve pain or preparing for surgery to optimise recovery time.

The panel also considers genes involved in neurochemical regulation, including serotonin and catecholamine pathways, as well as endogenous opioid and endocannabinoid signalling allowing for assessment of medication responses. Individual variability in these systems may contribute to alterations in pain thresholds, stress responsiveness and susceptibility to chronic pain patterns.

Results are interpreted alongside clinical history, injury patterns, psychological context and lifestyle factors. Integrating genetic insight with broader assessment can support more individualised discussion around recovery strategies, activity planning and long-term symptom management approaches.

Test type:

DNA: Gene, Pain

Sample required:

Dried Bloodspot 

Average processing time:

18-21 days

Privacy policy:

The DNA and the original sample material are destroyed after 3 months, so that there are no names or other identifiers on the samples. The samples are analysed only for the SNPs that are included in the tests at dnalife, and no other research or analyses are performed without a separate permission from the patient. We do not give or sell the results to any third parties.